A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal thoughts or attempts than those treated with behavioral interventions.

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.

Treatment with GLP-1 receptor agonists was associated with lower risks of suicidal ideation or attempts in adolescents with obesity compared with those who were treated with lifestyle interventions, a retrospective cohort study suggested.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third decreased risk for suicidal ideation and suicide attempts compared with lifestyle intervention alone, a large international retrospective study found.

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct.

The first country album to go platinum came out almost 50 years ago. See what it was, and look back on more country music milestones. 'It's not taxed at all': Warren Buffett shared the 'best investment' you can make when battling inflation — here are a few ways to put it into action Trump Pennsylvania Event Derailed After Audience Faintings 23 Certifications That Are Actually Easy To Get If You Want A High Paying Job Potential Tropical Storm Nadine Spaghetti Models Show Chances Of Hitting Florida Why do dogs sleep so much?

A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.